Corynebacterium glutamicum shows potential for high-yield de novo biosynthesis of 5-aminovaleramide—an important bio-based monomer.
Engineered strains produced 50% more 5-aminovaleramide compared to previous methods, enhancing viability for industrial applications.
Metabolic engineering strategies focused on optimizing specific pathways in Corynebacterium glutamicum to improve yield.
This approach highlights the importance of microbial systems for sustainable chemical manufacturing; further industrial applications are now encouraged.